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Background: In the present study, metabolite proﬁles of ginsenosides Rk1 and Rg5 from red ginseng or
red notoginseng in zebraﬁsh were qualitatively analyzed with ultraperformance liquid chromatography/
quadrupoleetime-of-ﬂight MS, and the possible metabolic were pathways proposed.
Methods: After exposing to zebraﬁsh for 24 h, we determined the metabolites of ginsenosides Rk1 and
Rg5. The chromatography was accomplished on UPLC BEH C18 column using a binary gradient elution of
0.1% formic acetonitrilee0.1% formic acid water. The quasimolecular ions of compounds were analyzed in
the negative mode. With reference to quasimolecular ions and MS2 spectra, by comparing with reference
standards and matching the empirical molecular formula with that of known published compounds, and
then the potential structures of metabolites of ginsenosides Rk1 and Rg5 were acquired.
Results: Four and seven metabolites of ginsenoside Rk1 and ginsenoside Rg5, respectively, were iden-
tiﬁed in zebraﬁsh. The mechanisms involved were further deduced to be desugarization, glucur-
onidation, sulfation, and dehydroxymethylation pathways. Dehydroxylation and loss of C-17 residue
were also metabolic pathways of ginsenoside Rg5 in zebraﬁsh.
Conclusion: Loss of glucose at position C-3 and glucuronidation at position C-12 in zebraﬁsh were
regarded as the primary physiological processes of ginsenosides Rk1 and Rg5.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Panax ginseng (PG) has been widely used as a general tonic in
traditional oriental medicine for over 2,000 y to increase disease
resistance, physical ﬁtness, and longevity, especially in elderly
people [1]. There are reports recorded that steamed ginseng pos-
sesses enhances pharmacological effects compared with non-
steamed ginseng [1]. Notoginseng, the dry root and rhizome of
Panax notoginseng (Burk.) F. H. Chen, has been one of the most
popular Chinese herbal medicines used for removing blood stasis,
stopping bleeding, relieving swelling, and alleviating pain in the
past hundreds of years [2]. Steamed notoginseng nourishes theMedicine Delivery System of Sta
anjing, 210028, China.
ht  2016, The Korean Society of G
d/4.0/).blood, enhances immune function, inhibits tumors, increases
robustness, and promotes tissue regeneration [2]. These activities
of ginseng and notoginseng are known to mainly originate from
ginsenosides [3e5]. During the steaming process, the chemicals are
transformed. Some compounds disappear, and some of the active
compounds are produced. Reports show that saponin compounds
including ginsenosides F4, Rg6, Rh2, Rk3, Rh4, Rk1, Rg5, and Rg3
can be isolated from steamed ginseng and notoginseng [6,7].
Among them, ginsenosides Rk1 and Rg5 are both protopanoxadiol
disaccharide glycosides [position C-3 is connected with glucose-(2-
1)-glucose] whose dehydrated positions are at C-20. The only dif-
ference in structure between ginsenoside Rk1 and ginsenoside Rg5te Administration of Traditional Chinese Medicine, Jiangsu Provincial Academy of
inseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
W. Shen et al / Metabolism of ginsenosides Rk1 and Rg5 79is the C-20 double bond position. The former position is at double
bond D20,21, while the latter position is at double bond D20,22.
Pharmacological references published have demonstrated memory
enhancing and neuroprotective effects of ginsenoside Rk1 [8].
Ginsenoside Rg5 is associated with reinforcement of cytotoxic
effectiveness in human hepatoma SK-HEP-1 cells [9]. Anti-
coagulation, antianxiety, and induction of neuronal differentiation
in neurosphere stem cells of ginsenoside Rg5 also have been re-
ported [10,11]. However, the metabolism of ginsenoside Rk1 and
Rg5 has not been reported yet in vitro and in vivo. The metabolic
study method in vitro is simple to perform but a high standard of
experimental conditions is necessary, and the approach in vivo is
resource costly and highly labor intensive. Many results show that
studying the metabolism in vivo is more accurate than in vitro.
In vitrometabolism experiments often neglect the interaction of the
body, so there is the absence of consistency with metabolism
in vivo. The experimental results require validation of metabolic
consequences in vivo. In the overall consideration, we choose the
method in vivo. In terms of the experimental animals, rats are often
chosen as the object. Then we ﬁrst use zebraﬁsh as the model due
to lots of advantages of genetic and physiological characteristics.
Zebraﬁsh has similar genes and complex organ system just like the
mammals. In addition, zebraﬁsh possess similar types of metabolic
enzymes [12e14] and intestinal ﬂora [15] as those observed in
mammals. We used ultraperformance liquid chromatography/
quadrupoleetime-of-ﬂight (UPLC-Q-TOF)/MS, which can improve
the sensitivity, reduce experimental error, and contribute to the
reliability of the results. The similarities and differences of meta-
bolic behavior of ginsenoside Rk1 and Rg5 were estimated rapidly.
Our work supplied data for their metabolic mechanism investiga-
tion in vivo and research on druggability during development of
new drug on future.
2. Materials and methods
2.1. Chemicals
Ginsenoside Rk1 (purity > 98%, Batch No: 12052401) was pur-
chased from Must Biological Technology Company (Chengdu,
China), and ginsenoside Rg5 (purity > 98%, Batch No: 20100728)
was purchased from Yong Heng Biological Technology Company
(Shanghai, China). MS-grade formic acid was purchased from
Nanjing Chemical Reagent Co., Ltd. (Nanjing, China). Dimethyl
sulfoxide (DMSO) was purchased from Sinopharm Chemical Re-
agent Co. Ltd (Shanghai, China), and the other reagents and
chemicals were of analytical grade. HPLC-grade acetonitrile and
methanol were purchased from Merck (Darmstadt, Germany).
Deionized water was puriﬁed using the Milli-Q water puriﬁcation
system (Millipore, Bedford, MA, USA).
2.2. Animals
Adult zebraﬁsh (Danio rerio; age 6e10 mo, weight, 0.8e1.2 g) of
mixed sex were supplied by Model Animal Research Center of
Nanjing University (Nanjing, China), and acclimatized to tap water
in a glass aquarium for at least 10 d preceding experimentation.
Fish were kept at a temperature of 23  1C in a photoperiod of
12:12 h. The ﬁsh were fed daily during the acclimatization period,
and were fasted overnight before the day of the experiment.
2.3. Instruments
Acquity UPLC system (Waters Corp., Milford, MA, USA) furnished
with autosampler, a vacuum degasser, thermostatted column
compartment, and quadruple pump, and Synapt Q-TOF massspectrometer (Waters Corp.) furnished with an electrospray ioni-
zation (ESI) sourcewere used. KQ3200DE Digital UltrasonicWasher
(Kunshan Ultrasonic Instruments Co. Ltd., Kunshan, China); XW-
80A Vortex Mixer (Shanghai Huxi Scientiﬁc Instrument Factory,
Shanghai, China); Mettler Toledo AB135-S Analytical Balance
(Mettler Toledo, Schwerzenbach, Switzerland); Labconco Freezer
Dryer (Labconco, Kansas City, MO, USA); TGL-16G Desk Centrifuge
(Shanghai Anting Scientiﬁc Instrument Factory, Shanghai, China);
Organomation N- EVAP 112 Nitrogen Evaporator (Organomation
Associates, Inc., Berlin, MA, USA) were also used.
2.4. Drug administration and sample collection
Adult zebraﬁsh were separated into three experimental groups
of six ﬁsh each at random. After fasting for 12 h, these ﬁsh in each
group were kept individually in brown glass bottles maintaining at
a temperature of 23  1C in a waterbath with 30 mL solution: one
blank control group was exposed to 0.5% DMSO puriﬁed water
(blank zebraﬁsh group), two groups were exposed to 30 mL solu-
tion of ginsenoside Rk1 (0.78 mg/mL) or ginsenoside Rg5 (2.54 mg/
mL) in 0.5% DMSO puriﬁed water (drug zebraﬁsh groups). In
addition, the above solutions of 0.5% DMSO puriﬁed water, ginse-
noside Rk1 (0.78 mg/mL) and ginsenoside Rg5 (2.54 mg/mL) without
zebraﬁsh were used as blank solvent and blank drug controls. Both
zebraﬁsh body and solution of the blank zebraﬁsh group and drug
zebraﬁsh groupswere sampled at 24 h. The zebraﬁsh bodies of each
group were combined and washed quickly with puriﬁed water
three times, then weight after sacriﬁce and removal of ﬁns and
scales of ﬁsh and stored at 70C prior to analysis; the solution of
each group were also combined. Combined solutions of each group
were sampled and also stored at 70C prior to analysis. Solutions
of blank solvent and blank drug control groups were sampled same
as above at 24 h.
2.5. Sample preparation
The solution sample (30 mL) was freeze-dried to dryness, and
the residue dissolved in 90% methanol (1 mL). The solution was
ﬁltered through a 0.22-mm ﬁlter and 20 mL was injected into the
UPLC-Q-TOF/MS system for analysis. The zebraﬁsh body samples (6
ﬁsh in each group) were cut with scissors, and 1 g was sampled and
homogenized with physiological saline (5 mL), followed by
centrifugation at 1852 g for 10 min, then the supernatant was
mixed by vortexing with methanol at the ratio of 1:4 (v/v) three
times, followed by centrifugation at 1852 g for 10 min. The super-
natant was evaporated to dryness with nitrogen at room temper-
ature, and the residue was dissolved in 90% methanol (1 mL). After
ﬁltering through a 0.22-mm ﬁlter, 20 mL of the solution containing
1 g ﬁsh tissue/mL was introduced into the UPLC-Q-TOF/MS system
for analysis.
2.6. Analysis condition
Chromatography was accomplished using an ACQUITY UPLC
system (Waters) furnished with a conditioned autosampler at 4C.
The separationwas completed on an Acquity UPLC BEH C18 column
(i.d., 1.7 mm; 2.1 mm  50 mm; Waters Corp.). The column tem-
perature was kept at 35C. The mobile phase comprised 0.1% formic
acidewater (solvent A) and 0.1% formic acideacetonitrile (solvent
B). The linear gradient elution program was as follows: 0e4 min,
10e100% B; 4e4.3 min, 100e100% B; 4.3e4.7 min, 100e10% B; 4.7e
5 min, 10% B. The ﬂow velocity was 0.2 mL/min. The injection
volume was 5 mL.
The high-mass resolution experiments were carried out on a
Synapt Q-TOF mass spectrometer (Waters Corp.) furnished with an
Table 1
Accurate mass measurement for the ionized molecules of metabolites of ginsenoside Rk1 in zebraﬁsh
No. Formula tR (min) [MH] [MþHCOO] (mg/L error) Fragment ions of [MH]
or [MþHCOO] m/z
Part
calcd m/z exptl m/z mg/L error
Parent C42H70O12 4.01 765.4795 765.4792 0.4 811.4858 (1.7) d d
M1 C36H60O10S 3.26 683.3834 683.3824 0.8 d MS2[527.3030] Zebraﬁsh body
M2 C42H68O13 3.19 779.4587 779.4609 3.5 d MS2[515.3047] Zebraﬁsh body
M3 C47H76O17 3.00 911.5010 911.4960 4.9 d MS2[545.3144] Zebraﬁsh body
M4 C48H78O18 3.03 941.5115 941.5114 0.4 d MS2[501.2884], [573.3090] Zebraﬁsh body
M5 C42H68O13 3.62 779.4587 779.4595 1.7 d MS2[515.3047] Solution sample of zebraﬁsh
M6 C47H76O17 3.00 911.5010 911.5001 0.4 d MS2[545.3144] Solution sample of zebraﬁsh
J Ginseng Res 2017;41:78e8480electrospray ionization (ESI) source in the negative ion mode. The
capillary and cone voltages were 3,000 V and 30 V, respectively. The
desolvation gas (nitrogen) was set to 800 L/h at 400C, and the
source temperature was 100C. The mass range was scanned from
100 Da to 1,500 Da and corrected during acquisition using an
external reference (lock spray) comprising a solution of 600 ng/mL
leucine enkephalin (m/z 566.2771) infused at a rate of 5 mL/min. The
transfer collision energy (Ec) and trap Ec to acquire MS data were
4 eV and 2 eV, respectively, whereas the transfer Ec was 2 eV and
the trap Ec was 6 eV to acquire MS/MS data. The raw data were
collected and processed using MassLynx (version 4.1; Waters
Corp.).
3. Results
The full scan mass spectrum of fragment ions of the biosamples
acquired from zebraﬁsh treated with ginsenosides Rk1 and Rg5was
compared with that of biosamples acquired from blank zebraﬁsh
and blank solvent to identify the possible metabolites of ginseno-
sides Rk1 and Rg5. Two parent compounds and their metabolites
showed their quasimolecular ions [M-H] or [MþHCOO] in
negative mode, and were conﬁrmed by a general analysis of the MS
and MS/MS fragmentation behaviors and retention times. The
structures of most metabolites were also extrapolated. The major
product ions of the metabolites, along with their UPLC retention
times are shown in Tables 1 and 2.
3.1. Metabolites of ginsenoside Rk1 detected in zebraﬁsh body
samples and the solution sample of zebraﬁsh
In all, four metabolites (M1eM4) and two metabolites (M5, M6)
were tentatively characterized by MS and MS/MS in the zebraﬁsh
body and the solution sample of zebraﬁsh, respectively. (Table 1). Of
these, fourdM1, M2(M5), M3(M6), M4dare, to our knowledge,
reported for the ﬁrst time. The TOF-MS spectra of these metabolites
and the proposed major metabolic pathway of ginsenoside Rk1 in
zebraﬁsh are shown in Figs. 1 and 2, respectively.Table 2
Accurate mass measurement for the ionized molecules of metabolites of ginsenoside Rg
No. Formula tR(min) [MH] [MþHC
calcd m /z exptl m /z mg/L error
Parent C42H70O12 4.03 765.4795 765.4811 2.8 811.485
N1 C28H48O9S 3.03 559.2946 559.2946 0.9 d
N2 C48H78O18 2.91 941.5115 941.5109 0.1 d
N3 C28H48O9S 2.39 559.2946 559.2934 1.3 d
N4 C34H56O12 2.54 655.3699 655.3684 1.5 d
N5 C34H56O13 2.10 671.3648 671.3629 2.1 d
N6 C34H58O12 2.54 d d d 703.390
N7 C42H68O13 3.10 779.4587 779.4568 1.8 825.464
N8 C47H76O17 3.00 911.5010 911.5022 1.9 d
N9 C48H78O18 2.91 941.5115 941.5109 0.1 dThe molecular ions of M4 (m/z 941.5115) were produced by the
glucuronated conjugation of 176 Da, corresponding to the glucur-
onidation from the parent compound (P). Therefore, M4 (Fig. 1) was
thought to be the glucuronated product of ginsenoside Rk1 due to
glucuronidation at position C-12. According to the structure of
ginsenoside Rk1, M4was called ginsenoside Rk1-12-O-glucuronate.
The molecular ions at m/z 779.4587 (M2 and M5) and their
product ions atm/z 515.3047 andm/z 507.2781 (Fig. 1B) was 162 Da
less than m/z 941.5115 (M4) and its product ions at m/z 573.3090
and m/z 501.2884. Therefore, M2 and M5 were identiﬁed as the
losing one molecular glucose products of M4, and their positions of
loss of glucose were thought to be at C-10 0. According to the struc-
ture of M4, M2 and M5 were called ginsenoside Rk2-12-O-
glucuronate.
The molecular ions at m/z 911.5010 (M3 and M6) and their
product ions at m/z 545.3144 and m/z 545.3145 (Fig. 1C) was 30 Da
less than m/z 941.5115 (M4) and its product ions at m/z 573.3090
and m/z 501.2884. Therefore, M3 and M6 were identiﬁed as the
losing one molecular hydroxymethyl products of M4, and their
positions of loss of hydroxymethyl were thought to be at C-50 of
glucose. According to the structure of M4, M3 and M6 were called
500-dehydroxymethyl ginsenoside Rk1-12-O-glucuronate.
The molecular ions atm/z 683.3834 (M1) and its product ions at
m/z 527.3030 (Fig.1A) was 80 Damore than that of ginsenoside Rk2.
Therefore, M1 was identiﬁed as the sulfated product of ginsenoside
Rk2, and the sulfated position was thought to be at C-12. According
to the structure of ginsenoside Rk2, M1was called ginsenoside Rk2-
12-O-sulfate.
3.2. Metabolites of ginsenoside Rg5 detected in zebraﬁsh body
samples and the solution sample of zebraﬁsh
In all, two metabolites (N1, N2) and eight metabolites (N3eN9)
were tentatively characterized by MS and MS/MS in the zebraﬁsh
body and the solution sample of zebraﬁsh, respectively (Table 2). Of
these, sevendN1(N3), N2(N9), N4eN8dare, to our knowledge,
reported for the ﬁrst time. The TOF-MS spectra of these metabolites5 in zebraﬁsh
OO] (mg/L error) Fragment ions of [MH]
or [MþHCOO] m/z
Part
6 (0.3) d d
MS2[513.2891] Zebraﬁsh body
MS2[599.3195], [615.3898] Zebraﬁsh body
MS2[513.2891] Solution sample of zebraﬁsh
MS2[475.2688] Solution sample of zebraﬁsh
MS2[539.3220] Solution sample of zebraﬁsh
6 (0.1) MS2[657.3842] Solution sample of zebraﬁsh
0 (0.4) MS2[599.3204] Solution sample of zebraﬁsh
MS2[545.3146], [599.3203] Solution sample of zebraﬁsh
MS2[599.3195], [615.3898] Solution sample of zebraﬁsh
Fig. 1. Mass spectra of metabolites of ginsenoside Rk1 in zebraﬁsh. (A) 23-de-2-methyl propenyl ginsenoside Rk2-12-O-sulfate, M1; (B) ginsenoside Rk2-12-O-glucuronate, M2 and
M5; (C) 500-dehydroxymethyl ginsenoside Rk1-12-O-glucuronate, M3 and M6; and (D) ginsenoside Rk1-12-O-glucuronate, M4.
W. Shen et al / Metabolism of ginsenosides Rk1 and Rg5 81and the proposed major metabolic pathway of ginsenoside Rg5 in
zebraﬁsh are shown in Figs. 3 and 4, respectively.
The molecular ions of N1 and N3 (m/z 559.2946) were produced
by the addition of 206 Da, corresponding to the desugarization,Fig. 2. Proposed major metabolic pathway of ginsenoside Rk1 in zebraﬁsh. (A) Dessulfation, de-1,5-dimethyl-1,4-hexadienyl, dehydroxylation of the
parent compound. These results indicate that the ions of the parent
compound were ﬁrst desugarized at positions C-3 and the ions of
ginsenoside Rh3, which then sulfated, losing 1,5-dimethyl-1,4-ugarization; (B) glucuronidation; (C) sulfation; and (D) dehydroxymethylation.
J Ginseng Res 2017;41:78e8482hexadienyl, dehydroxy was formed. Therefore, N1 and N3 (Fig. 2A)
were thought to be the sulfated, losing 1,5-dimethyl-1,4-hexadienyl,
dehydroxy products of ginsenoside Rh3. The positions of sulfation,
losses of 1,5-dimethyl-1,4-hexadienyl and dehydroxylation are C-
12,C-17 andC-20 of glucose, respectively. According to the structureof
ginsenoside Rh3, N1 and N3 were called 20-dehydroxyl, 17-de-1,5-
dimethyl-1,4-hexadienyl ginsenoside Rh3-12-O- sulfate.
The molecular ions at m/z 941.5115 (N2 and N9) and their
product ions atm/z 615.3898 andm/z 599.3195 (Fig. 2B) was 176 Da
more than themolecular ions of ginsenoside Rg5. Therefore, N2 and
N9 were identiﬁed as the glucuronated products of ginsenoside
Rg5, and the glucuronated position was thought to be at C-12. Ac-
cording to the structure of ginsenoside Rg5, N2 and N10were called
ginsenoside Rg5-12-O-glucuronate.
The molecular ions at m/z 779.4587 (N7) whose formic acid
association ion was at m/z 825.4642 and its product ion was at m/z
599.3204 (Fig. 2F) was 162 Da less than m/z 941.5115 (N2 and N9).
Therefore, N7 was identiﬁed as the losing one molecular glucose
product of N2 and N9 due to loss of glucose at position C-20. Ac-
cording to the chemical structures of N2 and N9, N7 was called
ginsenoside Rh3-12-O-glucuronate.Fig. 3. Mass spectra of metabolites of ginsenoside Rg5 in zebraﬁsh. (A) 20-dehydroxyl, 17-de-
Rg5-12-O-glucuronate, N2 and N9; (C) 20-dehydroxyl, 17-de-1,5-dimethyl-1,4-hexadienyl
noside Rh3-12-O-glucuronate, N5; (E) 17-de-1,5-dimethyl-1,4-hexadienyl ginsenoside Rg5
noside Rg5-12-O-glucuronate, N8.The molecular ions at m/z 911.5010 (N8) and their product ions
atm/z 599.3203 andm/z 545.3146 (Fig. 2G) was 30 Da less thanm/z
941.5115 (N2 and N9) and their product ions atm/z 615.3898 andm/
z 599.3195. Therefore, N8 was identiﬁed as the losing hydrox-
ymethyl product of N2 and N9, and the position of loss of
hydroxymethyl was thought to be at C-500 of glucose. According to
the structures of N2 and N9, N8 was called 500-dehydroxymethyl
ginsenoside Rg5-12-O-glucuronate.
The molecular ions of formic acid of association of N6 was atm/z
703.3910, and its product ions at m/z 657.3842 (Fig. 2E) was 108 Da
less than the parent compound (P). Therefore, N6 was identiﬁed as
the losing 1,5-dimethyl-1,4-hexadienyl product of ginsenoside Rg5
due to loss of 1,5-dimethyl-1,4-hexadienyl at position C-17. Ac-
cording to the chemical structure of ginsenoside Rg5, N6 was called
17-de-1,5-dimethyl-1,4-hexadienyl ginsenoside Rg5.
The molecular ions at m/z 671.3648 (N5) and its product ions at
m/z 539.3220 (Fig. 2D)was 14Damore than that of N6whose formic
acid association ionswas atm/z 703.3910 and its product ions atm/z
657.3842. Therefore, N5 was identiﬁed as the losing one molecular
glucose and the glucuronated product of N6, due to the losses of
glucose at position C-100 of glucose and the glucuronated position at1,5-dimethyl-1,4-hexadienyl ginsenoside Rh3-12-O- sulfate, N1 and N3; (B) ginsenoside
ginsenoside Rh3-12-O-glucuronate, N4; (D) 17-de-1,5-dimethyl-1,4-hexadienyl ginse-
, N6; (F) ginsenoside Rh3-12-O-glucuronate, N7; and (G) 500-dehydroxymethyl ginse-
W. Shen et al / Metabolism of ginsenosides Rk1 and Rg5 83C-12. According to the structures of N6, N5 was called 17-de-1,5-
dimethyl-1,4-hexadienyl ginsenoside Rh3-12-O-glucuronate.
The molecular ions atm/z 655.3699 (N4) and its product ions at
m/z 475.2688 (Fig. 2C) was 16 Da less thanm/z 671.3648 (N5) and its
product ions at m/z 539.3220. Therefore, N4 was identiﬁed as the
dehydroxy products of N5, and the dehydroxy positionwas thought
to be at C0-2 of glucose. According to the structures of N5, N4 was
called 20-dehydroxyl, 17-de-1,5-dimethyl-1,4-hexadienyl ginseno-
side Rh3-12-O-glucuronate.
4. Discussion
The zebraﬁsh, a well-characterized vertebrate model, is being
applied to the ﬁelds of molecular genetics and developmental
biology, and is used as an increasingly popular preclinical testing
model organism in drug toxicology and screening, as its genes and
complex organs are similar to those found in mammals [16e19].
The conversion of drugs is related to their activation and inactiva-
tion in vivo. So we should pay more attention to applying zebraﬁsh
model for pharmaceutical metabolism [20e23]. In biology, zebra-
ﬁsh and humans have certain similarities, most human genes and
have zebraﬁsh gene orthologs. Zebraﬁsh whole-genomeFig. 4. Proposed major metabolic pathway of ginsenoside Rg5 in zebraﬁsh. (A) Desugariza
hexadienylation); (E) dehydroxymethylation; and (F) dihydroxylation.sequencing has been completed, the similarity of the zebraﬁsh
gene with human genes is 87%, and some studies have shown that
drug reactions in zebraﬁsh and humans have a very high similarity.
We here used zebraﬁsh as a model to study the metabolism of
ginsenosides Rk1 and Rg5 from steamed notoginseng. Zebraﬁsh are
exposed to ginsenosides Rk1 and Rg5 solutions, and they can absorb
compounds independently and continuously from the solution
through the skin and cavity (mouth). Metabolites of the drug are
continuously discharged towater along with thewaste of zebraﬁsh,
so we can determine part of the drug metabolic information by
analyzing the liquid composition changes. This method is simple
and feasible, which has overcomed the defects of big difference
between the results of metabolism in vitro and that of metabolism
in vivo, prediction difﬁculty and high labor intensity in vivo.
Zebraﬁsh have a variety of drug-metabolizing enzymes, such as
cytochrome P450 isoforms or conjugation enzymes including
glutathione-S-transferase, uridine diphosphoglucuronyl trans-
ferases, and sulfotransferases, which are similar to those of mam-
mals. The gene or amino acid sequence of metabolic enzymes of
zebraﬁsh is more than half identical to human [12,13]. Experi-
mental results suggest that ginsenosides Rk1 and Rg5 were
metabolized in zebraﬁsh by reaction of desugarization,tion; (B) glucuronidation; (C) sulfation; (D) loss of C-17 residue (de-1,5-dimethyl-1,4-
J Ginseng Res 2017;41:78e8484dihydroxylation, and dehydroxymethylation mediated by intestinal
bacteria and P450s enzymes and that of glucuronidation and sul-
fation mediated by uridine diphosphoglucuronyl transferases and
sulfotransferases. There are three glucuronidation, two sulfation,
and one dehydroxymethylation products in metabolites of ginse-
noside Rk1. There are ﬁve glucuronidation, one sulfation, two
dihydroxylation, and one dehydroxymethylation products in
metabolite of ginsenoside Rg5. There are only two and three me-
tabolites that were not deglycosylated in metabolites of ginseno-
sides Rk1 and Rg5, respectively. The information above can provide
for research on the metabolic mechanism of ginsenosides Rk1 and
Rg5 in mammals. The foundation can also provide for further
verifying and clarifying metabolism law of ginsenosides Rk1 and
Rg5 in vivo and play an important role on their effects.
After 24 h metabolism in zebraﬁsh, the chromatography and
mass spectrum signal of product of loss of glucose at position C-3
and glucuronidation at position C-12 were powerful. The result
indexes that loss of glucose and glucuronidation is the main
physiological process of metabolism of ginsenosides Rk1 and Rg5 in
zebraﬁsh. In addition, content estimate of ginsenoside Rk1 in so-
lution sample of zebraﬁsh is more than that of ginsenoside Rg5,
which indicates that the metabolic rate of ginsenosides Rk1 is
slower than that of ginsenoside Rg5. The possible reason may be
that the position of C-20 double bond is altered, which leads to
distinction of solubility and permeability between ginsenoside Rk1
and ginsenoside Rg5.
In conclusion, UPLC-Q-TOF/MS was applied to the complicated
metabolites of ginsenosides Rk1 and Rg5 in zebraﬁsh, which pro-
vided an accurate detection method. For the ﬁrst time, totals of four
and seven metabolites of ginsenosides Rk1 and Rg5 were detected
and tentatively identiﬁed from the zebraﬁsh body and solution
samples of zebraﬁsh, respectively. From the experimental results,
we found that the main Phase II metabolism of ginsenosides Rk1
and Rg5 in zebraﬁsh was glucuronidation reactions. The possible
metabolic pathways of ginsenosides Rk1 and Rg5 were subse-
quently offered. We speculated on the percent of mass peak area
that ginsenoside Rk1-12-O-glucuronate was the predominant
metabolite of ginsenoside Rk1, and ginsenoside Rg5-12-O-glucur-
onate was the predominant metabolite of ginsenoside Rg5.
Although the structures of metabolites cannot be measured
conclusively by UPLC-Q-TOF/MS alone, the current method is al-
ways very worthy and reliable for the further investigation of the
metabolism of ginsenosides Rk1 and Rg5. In addition, we discov-
ered that the metabolic velocity of ginsenosides Rg5 is faster than
that of ginsenoside Rk1 on account of the difference of C-20 double
bond. This research offers a new model of exploring the drug
metabolism, and also provides a detection method for identifying
the metabolites.
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